Archer Diagnostics Profile
Key Indicators
- Authorised Capital ₹ 2.00 M
as on 03-01-2025
- Paid Up Capital ₹ 1.96 M
as on 03-01-2025
- Company Age 30 Year, 4 Months
- Last Filing with ROC 31 Mar 2023
- Satisfied Charges ₹ 1.26 Cr
as on 03-01-2025
- Revenue 179.32%
(FY 2021)
- Profit -104.51%
(FY 2021)
- Ebitda -183.55%
(FY 2021)
- Net Worth -3.94%
(FY 2021)
- Total Assets -13.60%
(FY 2021)
About Archer Diagnostics
The Company is engaged in the Chemicals And Materials Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 2.00 M and a paid-up capital of Rs 1.96 M.
The company has closed loans amounting to ₹1.26 Cr, and has no open charges as per Ministry of Corporate Affairs (MCA) records.
Thattaliyath Prakash and Anil Jose serve as directors at the Company.
- CIN/LLPIN
U85195KL1994PTC008111
- Company No.
008111
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
25 Aug 1994
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Ernakulam
Industry
Company Details
- Location
Ernakulam, Kerala, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Archer Diagnostics?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Thattaliyath Prakash  | Managing Director | 25-Aug-1994 | Current |
Board Members(1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Anil Jose | Director | 05-Mar-2021 | Current |
Financial Performance of Archer Diagnostics.
Archer Diagnostics Pvt Ltd, for the financial year ended 2021, experienced significant growth in revenue, with a 179.32% increase. The company also saw a substantial fall in profitability, with a 104.51% decrease in profit. The company's net worth dipped by a decrease of 3.94%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Archer Diagnostics?
In 2020, Archer Diagnostics had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Indian Overseas Bank Creation Date: 11 Jan 2014 | ₹0.36 M | Satisfied |
Indian Overseas Bank Creation Date: 23 Jan 2007 | ₹0.20 M | Satisfied |
Indian Overseas Bank Creation Date: 15 Dec 2004 | ₹0.90 M | Satisfied |
How Many Employees Work at Archer Diagnostics?
Archer Diagnostics has a workforce of 0 employees as of Mar 29, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Archer Diagnostics, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Archer Diagnostics's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
